ABSTRACT:
The landscape of diabetes management in 2026 is defined by the seamless integration of Artificial Intelligence (AI) and Digital Health technologies, transitioning care from episodic clinic visits to continuous, data-driven oversight. At the core of this evolution is the Digital Twin concept—a dynamic, AI-generated virtual model of a patient’s unique metabolism that predicts glucose responses to specific foods, stress, and medications. Modern care leverages Machine Learning (ML) to analyze high-frequency data from Continuous Glucose Monitoring (CGM) and smart wearables, enabling Automated Insulin Delivery (AID) systems to adjust dosing with near-physiological accuracy. Beyond glucose control, Generative AI (GenAI) and Agentic AI provide real-time, personalized coaching, while deep-learning algorithms screen for complications such as diabetic retinopathy and nephropathy with specialist-level precision. Despite challenges in data interoperability and algorithmic bias, these digital tools are essential for achieving Precision Medicine 2.0, reducing the cognitive burden on patients, and significantly improving Time-in-Range (TIR) through proactive, individualized interventions.